drugset / Trial / NCT03888378

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

NCT03888378

Phase 2 Completed 270 enrolled Hovione Scientia Limited
RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the efficacy and safety of two strengths of HY02 Ointment versus Vehicle administered twice daily for twelve weeks in subjects with a diagnosis of Inflamed Meibomian Gland Dysfunction.

Timeline

Start
2019-04-02
Primary completion
2020-09-18
Completion
2021-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Minocycline Small molecule 0.3 % Topical
Comparator Minocycline Small molecule 1 % Topical

Indications